Literature DB >> 4208274

Mechanisms and spectrum of streptomycin resistance in a natural population of Pseudomonas aeruginosa.

J T Tseng, L E Bryan, H M Van den Elzen.   

Abstract

A survey of 200 strains of Pseudomonas aeruginosa isolated from clinical specimens was made in an attempt to correlate the spectrum of their streptomycin resistance and the mechanism of resistance. The strains can be classified into three groups, according to their level of resistance to streptomycin: susceptible, low-level resistant, and high-level resistant strains. The mechanism of resistance of high-level resistant strains is either an R factor-mediated inactivation of streptomycin by phosphorylation or streptomycin-resistant ribosomes. However, such high-level resistant strains comprised less than 10% of the total strains isolated; the majority of the strains resistant to streptomycin were of low-level resistance. The latter are associated with a diminished uptake of streptomycin, and no evidence of streptomycin inactivation, resistant ribosomes, or R factors could be detected. The most probable explanation of low-level resistance is reduced permeability to streptomycin. Modification of the growth medium used in uptake studies simultaneously affected strongly both streptomycin incorporation and the minimal inhibitory concentration of streptomycin.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4208274      PMCID: PMC444280          DOI: 10.1128/AAC.2.3.136

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  ACTINOMYCIN SENSITIVITY IN ESCHERICHIA COLI PRODUCED BY EDTA.

Authors:  L LEIVE
Journal:  Biochem Biophys Res Commun       Date:  1965-01-04       Impact factor: 3.575

2.  Adenylylstreptomycin, a product of streptomycin inactivated by E. coli carrying R factor.

Authors:  H Umezawa; S Takasawa; M Okanishi; R Utahara
Journal:  J Antibiot (Tokyo)       Date:  1968-01       Impact factor: 2.649

3.  Rapid inhibition of polypeptide chain extension by streptomycin.

Authors:  J Modolell; B D Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1968-12       Impact factor: 11.205

4.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

5.  3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa.

Authors:  H Umezawa; S Umezawa; T Tsuchiya; Y Okazaki
Journal:  J Antibiot (Tokyo)       Date:  1971-07       Impact factor: 2.649

6.  Biochemical studies on gentamicin resistance.

Authors:  N Tanaka
Journal:  J Antibiot (Tokyo)       Date:  1970-09       Impact factor: 2.649

7.  Transferable drug resistance in Pseudomonas aeruginosa.

Authors:  L E Bryan; H M Van Den Elzen; J T Tseng
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

8.  Release of alkaline phosphatase from cells of Pseudomonas aeruginosa by manipulation of cation concentration and of pH.

Authors:  K J Cheng; J M Ingram; J W Costerton
Journal:  J Bacteriol       Date:  1970-11       Impact factor: 3.490

9.  Streptomycin uptake by Mycobacterium tuberculosis.

Authors:  W H Beggs; N E Williams
Journal:  Appl Microbiol       Date:  1971-04

10.  Inactivation of kanamycin, neomycin, and streptomycin by enzymes obtained in cells of Pseudomonas aeruginoa.

Authors:  O Doi; M Ogura; N Tanaka; H Umezawa
Journal:  Appl Microbiol       Date:  1968-09
View more
  18 in total

Review 1.  Antibiotic resistance plasmids of Staphylococcus aureus and their clinical importance.

Authors:  R W Lacey
Journal:  Bacteriol Rev       Date:  1975-03

Review 2.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 3.  Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Authors:  K Mörike; M Schwab; U Klotz
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

4.  Ribosomal resistance of clinical enterococcal to streptomycin isolates.

Authors:  G M Eliopoulos; B F Farber; B E Murray; C Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

5.  Gentamicin resistance in Pseudomonas aeruginosa: R-factor-mediated resistance.

Authors:  L E Bryan; M S Shahrabadi; H M van den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

6.  In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.

Authors:  S A Kabins; C Nathan; S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

7.  Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa.

Authors:  L E Bryan; H M Van den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

8.  Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.

Authors:  L E Bryan; H M Van Den Elzen
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

9.  Mechanisms of R factor R931 and chromosomal tetracycline resistance in Pseudomonas aeruginosa.

Authors:  J T Tseng; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1973-05       Impact factor: 5.191

10.  Characteristics of R931 and other Pseudomonas aeruginosa R factors.

Authors:  L E Bryan; S D Semaka; H M Van den Elzen; J E Kinnear; R L Whitehouse
Journal:  Antimicrob Agents Chemother       Date:  1973-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.